- Home
- CNMD vs SDGR Comparison
CNMD vs SDGR Comparison
Compare CNMD & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNMD
- SDGR
- Stock Information
- Founded
- CNMD 1970
- SDGR 1990
- Country
- CNMD United States
- SDGR United States
- Employees
- CNMD N/A
- SDGR N/A
- Industry
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- CNMD Health Care
- SDGR Health Care
- Exchange
- CNMD Nasdaq
- SDGR Nasdaq
- Market Cap
- CNMD 2.2B
- SDGR 1.8B
- IPO Year
- CNMD 1987
- SDGR 2020
- Fundamental
- Price
- CNMD $58.84
- SDGR $19.96
- Analyst Decision
- CNMD Buy
- SDGR Buy
- Analyst Count
- CNMD 5
- SDGR 7
- Target Price
- CNMD $77.20
- SDGR $32.29
- AVG Volume (30 Days)
- CNMD 488.0K
- SDGR 891.3K
- Earning Date
- CNMD 04-23-2025
- SDGR 04-30-2025
- Dividend Yield
- CNMD 1.36%
- SDGR N/A
- EPS Growth
- CNMD 108.33
- SDGR N/A
- EPS
- CNMD 4.25
- SDGR N/A
- Revenue
- CNMD $1,307,015,000.00
- SDGR $207,539,000.00
- Revenue This Year
- CNMD $5.97
- SDGR $28.69
- Revenue Next Year
- CNMD $5.63
- SDGR $14.95
- P/E Ratio
- CNMD $13.85
- SDGR N/A
- Revenue Growth
- CNMD 5.00
- SDGR N/A
- 52 Week Low
- CNMD $55.22
- SDGR $16.67
- 52 Week High
- CNMD $80.65
- SDGR $29.15
- Technical
- Relative Strength Index (RSI)
- CNMD 42.34
- SDGR 39.05
- Support Level
- CNMD $58.92
- SDGR $21.34
- Resistance Level
- CNMD $61.25
- SDGR $22.85
- Average True Range (ATR)
- CNMD 2.08
- SDGR 1.14
- MACD
- CNMD 0.24
- SDGR -0.21
- Stochastic Oscillator
- CNMD 14.76
- SDGR 5.06
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.